PlainRecalls
FDA Drug Moderate Class II Terminated

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Reported: October 25, 2023 Initiated: October 2, 2023 #D-0064-2024

Product Description

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
Pine Pharmaceuticals, LLC
Units Affected
860 syringes
Distribution
Nationwide within the United States
Location
Tonawanda, NY

Frequently Asked Questions

What product was recalled?
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.. Recalled by Pine Pharmaceuticals, LLC. Units affected: 860 syringes.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on October 25, 2023. Severity: Moderate. Recall number: D-0064-2024.